NAMPT and colitis: NMN administration activated the NAMPT-dependent NAD+ biosynthetic pathway, increased NAD+ content, and inhibited DSS-induced colitis disease severity in mice, suggesting that NMN might be a new therapeutic strategy for IBD [261].